Subacute stent thrombosis in a nonselected population using antiplatelet therapy: Frequency and predictors;Trombosis subaguda con tratamiento antiagregante en una poblacion no seleccionada de stents intracoronarios: Incidencia y predictores

Revista Espanola de Cardiologia

Volumn 53, Issue 6, 2000, Pages 791-796

  Pascual Figal, Domingo A ^a   Valdés Chávarri, Mariano ^a,b   Ruipérez, Juan A ^a   Cortés, Rocío ^a   López Pálop, Ramon ^a   Picó Aracil, Francisco ^a   García Alberola, Arcadio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b Portillo de San Antonio 8 5   (Spain)

Author keywords

Stent; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CORONARY STENT; DRUG EFFECT; FEMALE; FREQUENCY ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POPULATION RESEARCH; PREDICTION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

EID: 0033929951     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(00)75159-1     Document Type: Article

References (24)

1. Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: envolving issues and current concepts. J Am Coll Cardiol 1996; 27: 494-503.
2. Holmes D, Garratt K, Schwartz R. Timing of stent occlusion/ thrombosis after stent placement. J Am Coll Cardiol 1994; 23: 70A.
3. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-1688.
4. Morice MC, Zemour G, Benveniste E, Biron Y, Bourdonnec C, Faivre R et al. Intracoronary stenting without coumadin: one month results of a French multicenter study. Cathet Cardiovasc Diagn 1995; 35: 1-7.
5. Goods CM, Al-Shaibi KF, Yadav SS, Liu MW, Negus BH, Iyer SS et al. Utilization of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasound. Circulation 1996; 93: 1803-1808.
6. Karrillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French Registry Study. Circulation 1996; 94: 1519-1527.
7. Valdés M, Pinar E, Pascual D, Pérez-Lorente F, López-Candel J, García J et al. Complications at the first month following various types of intracoronary stents, implanted with high pressure without intracoronary ultrasonography or anticoagulation. Rev Esp Cardiol 1996; 49: 432-438.
8. Shömig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996; 334: 1084-1089.
9. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KKL et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998; 339: 1665-1671.
10. Urban F, Macaya C, Rupprecht HJ, Kiemeneij F, Emanuelsson H, Fontanelli A et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high risk patients. Circulation 1998; 98: 2126-2132.
11. Bertrand ME, Legrand V, Boland J, Flecke E, Emmanuelson H, Vrolix M et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study. Circulation 1998; 98: 1597-1603.
12. Schühlen H, Hadamitzky M, Walter H, Ulm K, Schomig A. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement. Analysis of a prospective Risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. Circulation 1997; 95: 2015-2021.
13. Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 1997; 29: 6-12.
14. Berger PB, Bell MR, Grill DE, Melby S, Holmes DR. Frequency of adverse clinical events in the 12 months following successful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin). Am J Cardiol 1998; 81: 713-718.
15. Zidar JP. Rationale for low-molecular weight heparin in coronary stenting. Am Heart J 1997; 134: S81-S87.
16. Nakamura S, Hall P, Gaglione A, Tiecco F, Di Maggio M, Maiello L et al. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol 1997; 29: 21-27.
17. Agrawal SK, Ho DS, Liu MW, Iyer SS, Hearn JA, Cannon AD et al. Predictors of thrombotic complications after placement of the flexible coil stent. Am J Cardiol 1994; 73: 1216-1221.
18. Schülen H, Kastrati A, Dirschinger J, Hausleiter J, Elezi S, Wehinger A et al. Intracoronary stenting and risk for major adverse cardiac events during the firs month. Circulation 1998; 98: 104-111.
19. Rupprecht HJ, Darius H, Borkowski U, Voigtländer T, Nowak B, Genth S et al. Comparison of antiplatelet effects of aspirin, ticlopidine or their combination after stent implantation. Circulation 1998; 97: 1046-1052.
20. Albiero R, Hall P, Itoh A, Blengino S, Nakamura S, Martini G et al. Results of a consecutive series of patients receiving only anti-platelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation 1997; 95: 1145-1156.
21. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996; 93: 215-222.
22. Barragan P, Sainsous J, Silvestri M, Simeoni JB, Bayet G, Roquebert PO et al. Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: prospective study of 1.051 consecutive patients. Cathet Cardiovasc Diagn 1997; 42: 363-373.
23. Elsner M, Peifer A, Drexler M, Wenzel Z, Hebbeker C, Kasper W et al. Clinical outcome at six months of coronary stenting followed by ticlopidine monotherapy. Am J Cardiol 1998; 81: 147-151.
24. Machraoui A, Germing A, von Dryander S, Grewe PH, Jager D, Bojara W et al. Efficacy and safety of ticlopidine alone vs ticlopidine and aspirin in post-stenting medical treatment: results of a randomized clinical trial [resumen]. Circulation 1997; 96 (Supl): 593.